| Financial Year |
March 31 2023 |
| Monetary Funds |
13,625,123,007.17 |
| Held-for-trading Financial Assets |
8,960,999.24 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,624,485,327.49 |
| Advances to Suppliers |
24,517,348,739.64 |
| Other Receivables |
2,374,943,273.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,444,218,478.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,587,264,233.00 |
| Other Current Assets |
947,403,502.78 |
| Total Current Assets |
72,477,576,612.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,034,094,378.29 |
| Long-term Equity Investment |
2,016,587,102.66 |
| Investment Properties |
478,658,815.00 |
| Fixed Assetes |
11,981,415,639.00 |
| Under-construction Projects |
108,691,979.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,375,683,970.39 |
| R&D expenses |
-- |
| Goodwill |
18,748,831,704.13 |
| Long-Term Deferred and Prepaid Expenses |
1,204,924,131.59 |
| Deferred Income Tax Assets |
683,642,842.15 |
| Other Non-Current Assets |
356,738,926.82 |
| Sub-Total of Non-Current Assets |
51,426,960,851.89 |
| Total Assets |
123,904,537,464.38 |
| Short-Term Loans |
36,227,637,962.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,278,524,697.33 |
| Accounts Payable |
1,632,534,516.97 |
| Accounts Received In Advance |
4,246,058.50 |
| Employee Compensation Payable |
191,755,652.05 |
| Taxes Payable |
1,319,023,449.20 |
| Interest Payable |
-- |
| Dividend Payable |
52,246,078.65 |
| Other payables |
2,653,714,632.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,219,717,238.29 |
| Other Current Liabilities |
185,743,063.19 |
| Sub-Total of Current Liabilities |
63,399,362,681.59 |
| Long-term Loans |
5,852,935,878.50 |
| Bonds Payable |
5,548,114,112.18 |
| Long-Term Accounts Payable |
10,122,497.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,524,045.28 |
| Deferred Income Tax Liabilities |
1,703,670,932.19 |
| Other Non-Current Liabilities |
126,204,241.05 |
| Sub-Total of Non-Current Liabilities |
15,837,986,326.69 |
| Total Liabilities |
79,237,349,008.28 |
| Paid-In Capital(Or Share Stock) |
8,111,268,382.00 |
| Capital Surplus |
12,953,486,664.36 |
| Surplus Reserve |
605,551,986.91 |
| LESS:Treasury Stock |
243,559,254.77 |
| Undistributed Profits |
17,485,899,928.54 |
| Minority Stockholder's Interest |
5,211,544,250.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,455,644,205.51 |
| Owner's Equity（Stockholder's Equity） |
44,667,188,456.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
123,904,537,464.38 |
